Franklin Resources’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Sell
9,484
-70,548
-88% -$2.08M ﹤0.01% 2695
2026
Q1
$2.22M Sell
80,032
-26,085
-25% -$670K ﹤0.01% 1882
2025
Q4
$2.3M Buy
106,117
+57,564
+119% +$1.14M ﹤0.01% 1721
2025
Q3
$735K Sell
48,553
-39,942
-45% -$494K ﹤0.01% 2261
2025
Q2
$997K Buy
+88,495
New +$959K ﹤0.01% 1992
2024
Q3
Sell
-1,145,203
Closed -$12.1M 3013
2024
Q2
$12.1M Buy
1,145,203
+5,958
+0.5% +$65.3K ﹤0.01% 1010
2024
Q1
$12M Buy
+1,139,245
New +$12.3M ﹤0.01% 1016
2023
Q4
Sell
-1,678,159
Closed -$19.6M 2705
2023
Q3
$19.6M Buy
1,678,159
+53,105
+3% +$600K 0.01% 749
2023
Q2
$16.4M Buy
1,625,054
+4
+0% +$36 0.01% 815
2023
Q1
$12M Buy
+1,625,050
New +$13.4M 0.01% 885

Other funds holding ROIV

Franklin Resources's ROIV Position: Q2 2026 in Review

Franklin Resources reduced its Roivant Sciences (ROIV) stake by 88% in Q2 2026, selling an estimated $2.08M and leaving 9,484 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #2695.

Franklin Resources first reported a position in ROIV in Q1 2023 and has held it in 10 quarters since. The position peaked at $19.6M in Q3 2023. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Franklin Resources held 9,484 shares of Roivant Sciences worth $336K as of Q2 2026.
  • Franklin Resources sold 70,548 Roivant Sciences shares in Q2 2026, an estimated $2.08M.
  • Roivant Sciences made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2695 holding.
  • Franklin Resources first reported a position in Roivant Sciences in Q1 2023 and has held it in 10 quarters since.
  • Franklin Resources's Roivant Sciences position peaked at $19.6M in Q3 2023.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.